Abstract
The "Synergy" project is part of one of the frontier issues concerning nanomedicine and focuses on the creation of an innovative "teranostic" platform, capable of simultaneously making diagnosis and therapy, based on the use of the fullerene-protein system for the detection and selective destruction of cancer cells.
Thanks to their peculiar chemical-physical properties, fullerenes are efficient imaging agents and sensitizers that can be used in photodynamic, sonodynamic and photothermal therapy.
Such non-invasive therapies, which use soft sources such as visible light or ultrasound, can be used to treat different types of tumors. To date, the application of fullerenes in the biomedical field has found significant limitations due to their insolubility in an aqueous environment.
The use of proteins as supramolecular "trojan horses" offers the opportunity to i) preserve the chemical nature (and intrinsic properties) of fullerenes; ii) solubilize the fullerenes, preventing aggregation phenomena; iii) shield the fullerenes from the biological environment; iv) decorating the protein with agents capable of directing the biohybrid to specific tumor cells.
Head of the Hosting Lab
Prof. Calvaresi Matteo
Scientific leader
Dr. Matteo Di Giosia
Partnership
Alma Mater Studiorum - Università di Bologna (Italy)
Budget
€ 75.000,00 (25.000 €/year)